T180
NK2 Tachykinin Receptor human
recombinant, expressed in CHO cells, membrane suspension
Sign In to View Organizational & Contract Pricing.
Select a Size
About This Item
UNSPSC Code:
12352200
MDL number:
Product Name
NK2 Tachykinin Receptor human, recombinant, expressed in CHO cells, membrane suspension
recombinant
expressed in CHO cells
form
membrane suspension
packaging
vial of 50 units
UniProt accession no.
shipped in
dry ice
storage temp.
−70°C
Quality Level
Gene Information
human ... TACR2(6865)
Analysis Note
Recommended assay conditions are supplied on the product data sheet. This is a bioassayed product.
Physical form
Supplied in 50 mM Tris-HCl, pH 7.4, containing 10% glycerol and 1% BSA. Actual concentrations and specific binding capacity are provided with each lot.
Regulatory Information
新产品
This item has
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
X P Zeng et al.
The Journal of urology, 153(5), 1688-1692 (1995-05-01)
Functional and radioligand binding studies with selective agonists and antagonists were used to investigate tachykinin receptors in the human bladder. Strips of detrusor muscle were contracted by the tachykinins neurokinin A and neuropeptide gamma, and by the NK2 receptor selective
Daolin Tang et al.
American journal of respiratory cell and molecular biology, 41(6), 651-660 (2009-03-07)
The pathogenesis of sepsis is mediated in part by the pathogen-associated molecular pattern molecule bacterial endotoxin, which stimulates macrophages to sequentially release early (e.g., TNF-alpha, IL-1beta) and late (e.g., high-mobility group box [HMGB] 1 protein) proinflammatory mediators. The recent discovery
Y Nakajima et al.
The Journal of biological chemistry, 267(4), 2437-2442 (1992-02-05)
The mammalian tachykinin system consists of three distinct peptides, substance P, substance K, and neuromedin K, and possesses three corresponding receptors. In this investigation we examined intracellular signal transduction of the individual tachykinin receptors by transfection and stable expression of
Long Sun et al.
Molecular medicine reports, 17(2), 3274-3280 (2017-12-20)
The purpose of the present study was to examine the effects of myricetin on reducing cerebral ischemia injury in a rat model. A rat model of permanent middle cerebral artery occlusion (pMCAO) was used in the present study. Rats were
Benjamin R Pryce et al.
Biochimica et biophysica acta. Molecular cell research, 1868(2), 118917-118917 (2020-12-02)
Duchenne's muscular dystrophy (DMD) is a severe muscle wasting disorder characterized by the loss of dystrophin expression, muscle necrosis, inflammation and fibrosis. Ongoing muscle regeneration is impaired by persistent cytokine stress, further decreasing muscle function. Patients with DMD rarely survive
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service